Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 934 000 KRW 0.21% Market Closed
Market Cap: 66.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Relative Value

The Relative Value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 665 751.32 KRW. Compared to the current market price of 934 000 KRW, Samsung Biologics Co Ltd is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
665 751.32 KRW
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
12
Median 3Y
17.5
Median 5Y
30.9
Industry
4
Forward
14.9
vs History
80
vs Industry
5
Median 3Y
70.1
Median 5Y
115.3
Industry
32.2
Forward
63.9
vs History
80
vs Industry
12
Median 3Y
53.1
Median 5Y
82.8
Industry
21.7
vs History
14
vs Industry
0
Median 3Y
90.1
Median 5Y
-68
Industry
34.2
vs History
63
vs Industry
16
Median 3Y
6.4
Median 5Y
6.9
Industry
2.6
vs History
79
vs Industry
12
Median 3Y
17.1
Median 5Y
30.8
Industry
3.8
Forward
14.8
vs History
79
vs Industry
9
Median 3Y
34.7
Median 5Y
66
Industry
8.3
vs History
82
vs Industry
10
Median 3Y
40.2
Median 5Y
69.8
Industry
18.6
Forward
35.9
vs History
76
vs Industry
6
Median 3Y
54.6
Median 5Y
85.7
Industry
23.2
Forward
47.8
vs History
80
vs Industry
12
Median 3Y
51.9
Median 5Y
81.5
Industry
20.7
vs History
42
vs Industry
6
Median 3Y
67.8
Median 5Y
56.5
Industry
28.4
vs History
61
vs Industry
20
Median 3Y
4.4
Median 5Y
5
Industry
2.3

Multiples Across Competitors

Competitors Multiples
Samsung Biologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW 15.8 64.6 34.7 49.7
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 461.9 4 943.2 1 559.9 3 324.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
196.3B USD 4.6 32 20.8 29.8
US
Danaher Corp
NYSE:DHR
170.3B USD 8 43.8 27.4 41.2
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.6 65.6 44.4 44.4
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 27.2 21.4 24.7
US
IQVIA Holdings Inc
NYSE:IQV
36.7B USD 2.4 26.1 14.3 21.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD 7 33.2 23.8 26.6
US
West Pharmaceutical Services Inc
NYSE:WST
23B USD 8 45.9 30.8 38.7
US
Illumina Inc
NASDAQ:ILMN
22.3B USD 5.1 -14.1 31.7 67.8
US
Waters Corp
NYSE:WAT
22.2B USD 7.6 35.6 22.8 27.9

See Also

Discover More
Back to Top